You searched for Humanized antibody - Page 36 of 45

Best in Biotech 20 May 2025

Seven lung cancer companies advancing new treatments in 2025

…of OST-HER2 in the U.S. Summit Therapeutics Technology: PD-1xVEGF bispecific antibody Lead candidate: Ivonescimab Recent news: Ivonescimab met its primary endpoint in another phase 3 trial for NSCLC Summit Therapeutics…

May 20, 2025 - 13 minutesmins - By Willow Shah-Neville

News and Trends 25 Nov 2021

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

…the European Commission gave its stamp of approval to two antibody treatments for Covid-19: regdanvimab from the South Korean firm Celltrion Healthcare, and a blend of two antibodies called casirivimab…

November 25, 2021 - 6 minutesmins - By Victor Kotsev

Best in Biotech 26 Jun 2023

Five animal health companies you should know about

…Parvovirus Monoclonal Antibody, which targets canine parvovirus (CPV); and Seresto for Dogs, for preventing ticks and fleas. Meanwhile, for farm animals, the company supports the prevention, control and treatment of…

June 26, 2023 - 6 minutesmins - By Willow Shah-Neville

More News! 22 Nov 2018

First Drug for Rare Inflammation Syndrome Approved by FDA

…antibody drug, emapalumab, is approved to treat primary hemophagocytic lymphohistiocytosis. This condition is a rare, often fatal syndrome in which the immune system produces too many activated immune cells, as…

November 22, 2018 - 2 minutesmins - By Jonathan Smith

The crucial role of GS-CHO innovation in biopharmaceutical progress

…cells, a cellular mechanism called antibody dependent cell-mediated cytotoxicity (ADCC) can enhance an antibody’s ability to destroy cancer cells. “We know that antibodies which lack the core N-glycan fucose sugar…

September 3, 2024 - 8 minutesmins - By Alexander Burik

derek jones babraham bioscience technologies incubator

Interview 20 Sep 2017

A Peek Inside Europe’s Best Incubator: A Conversation with Babraham’s Chief Executive

…field, Cambridge Antibody Technology, grew out of Babraham. Bicycle Therapeutics, Kymab, and Crescendo Biologics all count with former CAT employees and are now following in its footsteps to improve antibody-based…

September 20, 2017 - 9 minutesmins - By Evelyn Warner

Weekly Roundup 8 Dec 2023

Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer

…pan‑immunoglobulin (Ig) G protease sculpting (Sc) enzyme candidate (S-1117) and a PD-1 agonist:Fc gamma receptor IIb selective Dual-cell Bidirectional (DcB) antibody candidate (S-4321). The fundraising will also allow Seismic to…

December 8, 2023 - 14 minutesmins - By Willow Shah-Neville

In Depth 28 Jul 2022

How can vaccines keep up with evolving Covid-19 variants?

…the spike antigen becomes. This makes the key target of the antibody response more subject to mutations,” said Alexandre Le Vert, executive chairman and co-founder of the French vaccine firm…

July 28, 2022 - 7 minutesmins - By Jonathan Smith

Isogenica Maverick Therapeutics llama antibodies cancer 1

News and Trends 7 Feb 2017

British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy

Isogenica has licensed its synthetic llama antibody library to Maverick Therapeutics, which develops cancer T-cell therapies designed to reduce side effects. Isogenica is a synthetic biology company near Cambridge that…

February 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Jan 2017

This British Biotech is buying its way into the Crowded NASH Space

…fights inflammation by binding to the interleukin-6 receptor (IL-6R). Tiziana plans to use the antibody in combination with foralumab, an anti-CD3 antibody also licensed from Novimmune, for the treatment of…

January 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 30 Apr 2024

5 private biotech companies in China you should know about

…Junshi Biosciences Junshi Biosciences is developing an array of different medicines, having expanded from monoclonal antibodies to small molecule drugs, polypeptide drugs, ADCs, bispecific antibody or multispecific antibody drugs, nucleotide…

April 30, 2024 - 6 minutesmins - By Willow Shah-Neville

lupus autoimmune disease neutrophil citryll

More News! 26 Nov 2019

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

…disease than current treatments in a phase III trial. The drug avacopan was trialed in 331 patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. This life-threatening condition is also known as ANCA…

November 26, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Seven lung cancer companies advancing new treatments in 2025

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

Five animal health companies you should know about

First Drug for Rare Inflammation Syndrome Approved by FDA

The crucial role of GS-CHO innovation in biopharmaceutical progress

A Peek Inside Europe’s Best Incubator: A Conversation with Babraham’s Chief Executive

Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer

How can vaccines keep up with evolving Covid-19 variants?

British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy

This British Biotech is buying its way into the Crowded NASH Space

5 private biotech companies in China you should know about

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!